Vivimed Labs reports consolidated net loss of Rs 5.60 crore in the March 2025 quarter

Sales decline 33.69% to Rs 25.61 crore

Net loss of Vivimed Labs reported to Rs 5.60 crore in the quarter ended March 2025 as against net profit of Rs 5.26 crore during the previous quarter ended March 2024. Sales declined 33.69% to Rs 25.61 crore in the quarter ended March 2025 as against Rs 38.62 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 31.96 crore in the year ended March 2025 as against net loss of Rs 45.45 crore during the previous year ended March 2024. Sales declined 22.00% to Rs 116.27 crore in the year ended March 2025 as against Rs 149.07 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	25.61	38.62	-34	116.27	149.07	-22
OPM %	-9.64	-73.74	-	-11.22	-22.43	-
PBDT	0.01	12.49	-100	-11.62	-25.88	55
PBT	-5.49	6.65	PL	-31.85	-45.82	30
NP	-5.60	5.26	PL	-31.96	-45.45	30

Powered by Capital Market - Live News